Semaglutide

目录号: GC31404纯度: >98.00%同义词: 索马鲁肽

Semaglutide是人胰高血糖素样肽-1的长效类似物,可作为人胰高血糖素样肽-1 (GLP-1)受体的激动剂。

Cas No.: 910463-68-2

规格	价格	库存	数量
500μg	¥1,120.00	现货	1
1mg	¥1,820.00	现货	1
5mg	¥3,920.00	现货	1
10mg	¥5,600.00	现货	1

电话: 400-920-5774Email: sales@glpbio.cn

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例

Nature
641, 529–536 (2025)
Nature
628, 630–638 (2024)
Nature
632, 686–694 (2024)
Nature
618, 1017–1023 (2023)
Nature
610, 366–372 (2022)
Cell
187(9):2288-2304 (2024)
Cell
183(7):1867-1883 (2020)
Science
388(6745) (2025)
Science
387(6739) (2025)
Science
387(6734) (2025)
Cell Research
35, 97–116 (2025)
Cell Research
34, 683–706 (2024)
Cell Research
33, 273–287 (2023)
Cell Research
33, 546–561 (2023)
Cell Research
33, 904–922 (2023)
Cell Research
31, 1291–1307 (2021)

产品描述 Description

Semaglutide is a long-acting analogue of human glucagon-like peptide-1 and an agonist for the human glucagon-like peptide-1 (GLP-1) receptor. It reduces blood sugar, body weight and blood pressure and improves blood sugar control in adults with type 2 diabetes[1-2].

Semaglutide(900 nM; 24h) attenuated the LPS‑ and nigericin‑induced inflammatory response and LDH release by blocking NLRP3 inflammasome activation in BV2 cells[3]. Semaglutide(5nM; 30min) promoted expression of GLP1R and activated PKG/PKCε/ERK1/2 signaling pathway in H/R H9C2 cells[4].

Semaglutide(40 µg/kg once every 3 days；4weeks；s.q) showed significant anti-inflammatory effects and mitigated the ER stress in eWAT adipocytes of obese mice[5]. Semaglutide(30 nmol/kg/day ;i.p; 12 weeks)reduces body weight, improves glucose metabolism, inflammation and oxidative stress in obese mice[6]. Semaglutide(0.1 mg/kg; i. p ) reduced blood glucose and promoted glucose metabolism in the brain of 3xTg mice via the SIRT1 pathway[7].

References:
[1]. FrÍas JP, Davies MJ, et, al. SURPASS-2 Investigators. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. PMID: 34170647.
[2]. Chao AM, Tronieri JS, et, al. Semaglutide for the treatment of obesity. Trends Cardiovasc Med. 2023 Apr;33(3):159-166. doi: 10.1016/j.tcm.2021.12.008. Epub 2021 Dec 21. PMID: 34942372; PMCID: PMC9209591.
[3]. Wang L, Ding J, et, al. Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole‑kindled mice. Int J Mol Med. 2021 Dec;48(6):219. doi: 10.3892/ijmm.2021.5052. Epub 2021 Oct 22. PMID: 34676876; PMCID: PMC8547541.
[4]. Zhu Q, Luo Y, et, al. Semaglutide inhibits ischemia/reperfusion-induced cardiomyocyte apoptosis through activating PKG/PKCε/ERK1/2 pathway. Biochem Biophys Res Commun. 2023 Mar 5;647:1-8. doi: 10.1016/j.bbrc.2023.01.049. Epub 2023 Jan 17. PMID: 36706596.
[5]. Martins FF, Marinho TS, et, al. Semaglutide (GLP-1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice. Cell Biochem Funct. 2022 Dec;40(8):903-913. doi: 10.1002/cbf.3751. Epub 2022 Sep 28. PMID: 36169111.
[6]. Pan X, Yang L, et, al. Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression. Mol Cell Biochem. 2023 Jun 15. doi: 10.1007/s11010-023-04784-2. Epub ahead of print. PMID: 37318712.
[7]. Wang ZJ, Li XR, et, al. Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway. Neuropharmacology. 2023 Dec 1;240:109716. doi: 10.1016/j.neuropharm.2023.109716. Epub 2023 Sep 18. PMID: 37730113.

Semaglutide是人胰高血糖素样肽-1的长效类似物,可作为人胰高血糖素样肽-1 (GLP-1)受体的激动剂。它可以降低血糖、体重和血压,改善成人2型糖尿病患者的血糖控制[1-2]。

Semaglutide(900 nM; 24h)通过阻断BV2细胞中NLRP3炎性体的激活,减弱LPS和尼日利亚菌素诱导的炎症反应和LDH释放[3]。Semaglutide(5nM; 30min)在H/R H9C2细胞中促进GLP1R的表达,激活PKG/PKCε/ERK1/2信号通路[4]。

Semaglutide (40 µg/kg once every 3 days; 4weeks; s.q)具有显著的抗炎作用,可减轻肥胖小鼠eWAT脂肪细胞内质网应激[5]。Semaglutide(30 nmol/kg/day ; i.p; 12 weeks) 减轻体重,改善肥胖小鼠的葡萄糖代谢,炎症和氧化应激[6]。Semaglutide (0.1 mg/kg; i. p) 通过SIRT1途径降低3xTg小鼠的血糖并促进脑内葡萄糖代谢[7]。

实验参考方法 Experimental Reference Method

Cell experiment [1]:
Cell lines	BV2 cells
Preparation Method	Cells were assigned to four groups as follows: i) The control group, treated with 1% DMSO; ii) the semaglutide group, treated with 900 nM semaglutide; iii) the lipopolysaccharide (LPS) + nigericin group, treated with 1 µg/ml LPS and 10 µM nigericin; and iv) the semaglutide + LPS + nigericin group, treated with 900 nM semaglutide followed by 1 µg/ml LPS and 10 µM nigericin.
Reaction Conditions	900 nM; 24h
Applications	Semaglutide inhibits LPS- and nigericin-mediated lactate dehydrogenase (LDH) release in BV2 cells.
Animal experiment [2]:
Animal models	C57BL/6 male mice
Preparation Method	Normal mice and obese mice were randomly assigned to a diet plus Semaglutide or no Semaglutide. Semaglutide was administered subcutaneously to mice at 40 µg/kg once every 3 days (corresponding to 1.2 µg per animal). The stock semaglutide solution (1.34 mg/ml) was diluted in sterile 0.9% NaCl to 6.0 µg/ml so that an injection volume of 200 µl would contain 1.2 µg of the drug. Untreated groups were given sterile subcutaneous saline.
Dosage form	40 µg/kg once every 3 days; 4weeks; s.q
Applications	Semaglutide stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice.
References: [1]. Wang L, Ding J, et, al. Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole‑kindled mice. Int J Mol Med. 2021 Dec;48(6):219. doi: 10.3892/ijmm.2021.5052. Epub 2021 Oct 22. PMID: 34676876; PMCID: PMC8547541. [2]. Martins FF, Marinho TS, et, al. Semaglutide (GLP-1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice. Cell Biochem Funct. 2022 Dec;40(8):903-913. doi: 10.1002/cbf.3751. Epub 2022 Sep 28. PMID: 36169111.

产品文档 Product Documents

批次：Purity:>98.00%

化学性质Chemical Properties

CAS 号

910463-68-2

同义词

索马鲁肽

SMILES

[Semaglutide]

分子量

4113.58 g/mol

溶解性

DMSO：3mg/mL (0.73 mM); 50mg/ml in H<sub>2</sub>O

保存条件

Store at -20°C

General tips

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
为了提高溶解度，请将管子加热至 37°C，然后在超声波浴中震荡一段时间。

Shipping Condition

评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备 RT，或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

质量 (Mass)

体积 (Volume)

浓度 (Concentration)

分子量 (MW)

g/mol